Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Immune-Inflammation Index As a Predictor of Neoadjuvant Treatment Efficacy in Advanced Gastric Cancer Based on a Dynamic Clinical Model

NCT06706466 is registered in ClinicalTrials.gov with Chang-Ming Huang, Prof. as lead sponsor.

NCT NCT06706466
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706466 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Immune-Inflammation Index As a Predictor of Neoadjuvant Treatment Efficacy in Advanced Gastric Cancer Based on a Dynamic Clinical Model
Lead sponsor
Chang-Ming Huang, Prof.
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
May 1, 2024
Enrollment
410 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancers, immunotherapy gastrict cancer, inflammation biomarkers